1984
DOI: 10.1093/eurheartj/5.suppl_f.103
|View full text |Cite
|
Sign up to set email alerts
|

Distribution of myosin isozymes in human atrial and ventricular myocardium: comparison in normal and overloaded heart

Abstract: We have prepared monoclonal antibodies specific for either atrial or ventricular myosin and defined the isomyosin composition of myocardium in normal and overloaded human hearts. In the atrial myocardium, normal isozymic pattern was V1 dominant which converted to being V3 dominant in an overloaded condition. In contrast, normal isomyosin pattern of the ventricular myocardium was exclusively V3 dominant, and only a small change in the proportion of isomyosin was observed in an overloaded condition. From this, w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
17
0

Year Published

1986
1986
2007
2007

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(18 citation statements)
references
References 0 publications
1
17
0
Order By: Relevance
“…A rat anti-mouse CD18 mAb (M18/2, IgG2a) was purchased from American Type Culture Collection (Rockville, MD) ( 17). The preparation ofa mouse anti-cardiac myosin mAb (CMA 19) was previously described ( 18). The reactivity of CMAl9 for C3H/He mouse ventricular myosin heavy chain was confirmed by immunoblot analysis (data not shown).…”
Section: Ifn-y * Tnf-amentioning
confidence: 94%
“…A rat anti-mouse CD18 mAb (M18/2, IgG2a) was purchased from American Type Culture Collection (Rockville, MD) ( 17). The preparation ofa mouse anti-cardiac myosin mAb (CMA 19) was previously described ( 18). The reactivity of CMAl9 for C3H/He mouse ventricular myosin heavy chain was confirmed by immunoblot analysis (data not shown).…”
Section: Ifn-y * Tnf-amentioning
confidence: 94%
“…rat IgG2a) [14] were described elsewhere and were used for immunohistochemical study and in vivo mAb treatment study. The preparation of mouse anti-cardiac myosin mAb (CMA19) was as published elsewhere [20]. Another anti-mouse PD-1 mAb (hybridoma PIM-2, rat IgG2a) was recently developed.…”
Section: Monoclonal Antibodies (Mabs)mentioning
confidence: 99%
“…'3 Using immunofluorescent techniques, Gorza et al 14 and Yazaki et al 15 have suggested that human atrial tissue can respond to hemodynamic loads, as might be seen with mitral valvular disease, by altering the distribution of its specific isomyosins.…”
mentioning
confidence: 99%